Resolved hepatitis B is associated with higher reactivation risk than chronic infection after chemoembolization for hepatocellular carcinoma

Figure 3 Hepatitis B virus DNA kinetics after transarterial chemoembolization, according to reactivation status. Mean hepatitis B virus (HBV) DNA levels (log₁₀ IU/mL) with standard errors of the mean are shown at baseline and during follow-up intervals (0-3, 3-6, and 6-12 months after first transarterial chemoembolization) for patients with reactivation (orange) and those without reactivation (blue). Baseline values were obtained from the first available HBV DNA measurement. For each follow-up interval, the maximum HBV DNA value within that period was used when multiple measurements were available. The number of patients with data for each time point is shown below the X-axis (reactivation positive/reactivation negative). P values were calculated using the Mann-Whitney U test. HBV: Hepatitis B virus; TACE: Transarterial chemoembolization.